SynthesisNeurobiology of disease2025
Disentangling the inverse relationship between cancer and Alzheimer's or Parkinson's disease: A systematic review on Mendelian randomization studies.
Synthesis in Neurobiology of disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionAlthough studies have reported an inverse relationship between cancer and neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), findings remain inconsistent. Observational studies are limited by survival bias and reverse causation. To better understand the relationship, we conducted a systematic review of Mendelian randomization (MR) studies examining both directions-assessing cancer as a risk factor for AD or PD, as well as AD or PD as exposures influencing cancer risk.
methodsWe systematically reviewed MR studies investigating the causal relation between cancer and either AD or PD. Cancer could be specified as either an exposure or an outcome of interest. Articles published until August 2024 were identified, screened, and abstracted by two reviewers following the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)" guidelines.
resultsTwelve studies met the inclusion criteria, comprising data from approximately 10,000 individuals and examining over 20 cancer types in relation to AD and PD risk. Of these, seven studies focused on AD, three on PD, and two examined both. Among nine studies on AD, an inverse association between several cancers and AD was reported, especially with breast cancer (overall and estrogen receptor-positive), with reduced odds (OR < 1) using inverse variance weighting. Studies on PD yielded inconclusive evidence of any causal relationship with cancer.
conclusionThese results highlight inverse associations between AD and breast cancers, potentially implicating hormonal signaling pathways. Despite variations in methods and GWAS datasets, consistent protective trends were observed. However, further research is required to confirm causality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.